Midatech has announced an extension of the Q-Sphera R&D Collaboration (‘the Collaboration’) that was originally detailed on 21 July 2020, while also disclosing that the previously unnamed party is, in
Midatech Pharma PLC (MTPH.L) Breakthrough data using Q-Sphera technology
Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other R&D programmes
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech yesterday published a business update which included a number of elements of positive news. These included:
Midatech Pharma PLC (MTPH.L) Headline Results of MTX110 Phase I DIPG Study
Phase II Dose Confirmed and Encouraging Survival Data
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has today announced encouraging headline results from a Phase I study at the University of California, San Francisco (‘UCSF’) in patients with the orphan condition, Diffuse Intrinsic Pontine Glioma
TPI provides its latest research note on Midatech Pharma plc (MTPH.L)
Midatech has announced unaudited interim results for the six months ended 30 June 2020. These cover a period of significant transition for the Group, subsequent to which it has raised